관상동맥 중재술을 시술 받은 고령 환자들의 최근 10년간 임상 양상의 변화

Clinical pattern changes in elderly patients who underwent percutaneous coronary intervention in the last ten years

  • 김민석 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 정명호 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 황승환 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 고점석 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 이민구 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 심두선 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 박근호 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 윤남식 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 윤현주 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 김계훈 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 홍영준 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 김주한 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 안영근 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 조정관 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 박종춘 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터) ;
  • 강정채 (전남대학교 의학전문대학원 전남대학교병원 심장센터, 보건복지부 지정 심장질환 특성화 연구센터)
  • Kim, Min-Suk (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Jeong, Myung-Ho (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Hwang, Seung-Hwan (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Ko, Jum-Suk (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Lee, Min-Goo (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Sim, Doo-Sun (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Park, Keun-Ho (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Yoon, Nam-Sik (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Yoon, Hyun-Ju (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Kim, Kye-Hun (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Hong, Young-Joon (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Kim, Ju-Han (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Ahn, Young-Keun (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Cho, Jeong-Gwan (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Park, Jong-Chun (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School) ;
  • Kang, Jung-Chaee (The Heart Center of Chonnam National University Hospital, The Heart Research Center Designated by Korea Ministry of Health and Welfare, Chonnam National University Medical School)
  • 투고 : 2010.07.30
  • 심사 : 2010.09.28
  • 발행 : 2010.12.01

초록

목적: 우리나라에서 허혈성 심장 질환의 유병률이 높아지고 있으며, 관상동맥 중재술(percutaneous coronary intervention, PCI)이 중요한 치료 방법의 하나로서 시행되고 있다. 본 연구를 통하여 최근 10년간 PCI를 시행받은 65세 이상의 고령환자들의 임상양상의 변화를 확인하였다. 방법: 1999년 6월부터 2009년 6월까지 PCI를 시행받은 65세 이상의 3,209명[남성:여성 1950명($71.4{\pm}5.21$세):1,359명($72.5{\pm}5.47$세)]의 환자를 대상으로 하여 기간에 따라 4개의 군으로 나누었다. 네 군 간의 임상적 특징, 성별 간의 차이, 관상동맥 조영술 및 PCI 소견의 차이, 시술 후 1년 이내 주요 심장 사고의 발생을 분석, 비교하였다. 결과: 지난 10년간 PCI를 시술 받은 고령 환자의 성비는 지속적으로 남성의 비율이 높았다[남성(60.8%):여성(39.2%)]. 평균 연령은 지속적으로 증가하였으며, 위험인자의 경우 고혈압의 유병률은 증가하였으며(p=0.028), 흡연은 감소하였다. (p=0.002). 1년 이내 주요 심장 사고의 발생률은 지속적으로 감소하였으며(p=0.014), 남성은 여성보다 높은 생존율을 보였다(p=0.001). PCI 후 1년 이내의 주요 심장 사고는 105명(3.27%)에서 발생하였다. 주요 심장 사고의 발생 예측인자로는 여성(p=0.001), 75세 이상의 고령(p=0.008), 고혈압(p=0.049), 당뇨병(p=0.004), 흡연(p=0.009), 시술 후 낮은 TIMI flow (p=0.048) 등이었다. 결론: PCI를 시술 받은 고령 환자의 평균 연령은 지속적으로 증가하였으며, 고혈압은 지속적으로 상승하였고, 흡연은 감소하였다. 1년 이내 주요 심장 사고의 발생과 관련된 유의한 인자들은 여성, 고령, 고혈압, 당뇨병, 흡연, 시술 후 낮은 TIMI flow 등이었다.

Background/Aims: The objective of this study was to observe changes in the clinical patterns of Korean patients over 65 years of age who received percutaneous coronary intervention (PCI) in the past 10 years. Methods: In total, 3,209 patients over 65 years of age [male:female; 1,950 ($71.4{\pm}5.21$ years):1,259 ($72.5{\pm}5.47$ years)] who underwent PCI between June 1999 and June 2009 were divided into four groups according to time period. Clinical characteristics, gender differences, coronary angiographic findings, and major adverse cardiac events (MACE) during a 1-year follow-up period were compared among the four groups. Results: The gender ratio was male-dominant and no significant change was observed over the observed time period [male (60.8):female (39.2%)], but the age increased [1999-2001:2002-2004:2005-2007:2008-2009=$71.2{\pm}5.11$ : $71.4{\pm}5.26$ : $71.9{\pm}5.25$ : $72.6{\pm}5.57$ years; p=0.001]. The prevalence of hypertension increased over time (p=0.028), but smoking decreased (p=0.002). Hypertension was the major risk factor for males, whereas obesity was the major risk factor for female patients. MACE-free 1-year survival increased over the observed period (p=0.014). Males had higher survival rates than females (p=0.007). MACE developed in 105 (3.27%) patients during the 1-year follow-up period and predictive factors for the development of MACE were being female (p=0.001), old age (p=0.008), hypertension (p=0.049), diabetes mellitus (p=0.004), smoking (p=0.009), and low Thrombolysis In Myocardial Infarction (TIMI) flow (p=0.048) by a multivariate analysis. Conclusions: The age of elderly patients undergoing PCI and the prevalence of hypertension increased, whereas smoking decreased over the last 10 years. Predictive factors for patients developing MACE during the one-year follow-up were associated with female gender, hypertension, diabetes mellitus, smoking, old age, and low TIMI flow.

키워드

참고문헌

  1. Korea National Stat Office. Social indicators in Korea. 2009
  2. Cho JM, Kim CJ, Shin WS, Cho EJ, Park CS, Kim PJ, Lee JM, Ihm SH, Rhim HY, Chang K, Moon KW, Kim YJ, Jung HO, Kim HY, Park JW, Jin SW, Jeon HK, Oh YS, Yoo KD, Jeon DS, Baek SH, Lee GW, Youn HJ, Lee MY, Chung WS, Park JC, Seung KB, Rho TH, Kim CM, Park IS, Chae JS, Kim JH, Choi KB, Hong SJ. Clinical features and prognostic factors in Korean patients hospitalized for coronary artery disease. Korean J Med 73:142-150, 2007
  3. Rosendorff C, Black HR, Canno CP, Gersh BJ, Gore J, Izzo JL Jr, Kaplan NM, O'Connor CM, O'Gara PT, Oparil S. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115:2761-2788, 2007 https://doi.org/10.1161/CIRCULATIONAHA.107.183885
  4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62-S69, 2010 https://doi.org/10.2337/dc10-S062
  5. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment panel III guidelines. Circulation 110:227-239, 2004 https://doi.org/10.1161/01.CIR.0000133317.49796.0E
  6. Brunzell JD, Davidson M, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 31:811-822, 2008 https://doi.org/10.2337/dc08-9018
  7. Lee YE, Park JE, Hwang JY, Kim WY. Comparison of health risks according to the obesity types based upon BMI and waist circumference in Korean adults: the 1998-2005 Korean national health and nutrition examination surveys. Korean J Nutr 42:631-638, 2009 https://doi.org/10.4163/kjn.2009.42.7.631
  8. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2007 guidelines for the management of patients with unstable angina/ non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50:E1-E157, 2007 https://doi.org/10.1016/j.jacc.2007.11.004
  9. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P. Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation 76:142-154, 1987 https://doi.org/10.1161/01.CIR.76.1.142
  10. Kim W, Jeong MH, Yeom JH, Kim JH, Rhew JY, Ahn YK, Cho JG, Park JC, Kang JC. A case of acute myocardial infarction in an eighteen-year-old male patient. Korean J Med 63:572-576, 2002
  11. Lim SY, Jeong MH, Yang BR, Kim KH, Shon IS, Hong YJ, Park HW, Kim JH, Kim W, Ahn YK, Cho JG, Park JC, Kang JC. Long-term clinical outcomes after primary percutaneous coronary intervention in patients with acute myocardial infarction older than 75 years. Korean Circ J 35:613-619, 2005 https://doi.org/10.4070/kcj.2005.35.8.613
  12. Lee KH, Jung MH, Ahn YK, Kim JH, Chae SC, Kim YJ, Seong IW, Hong TJ, Choi DH, Cho MC, Kim CJ, Chung WS, Jang YS, Cho JG, Park SJ. Sex differences of the clinical characteristics and early management in the Korea acute myocardial infarction registry. Korean Circ J 37:64-71, 2007 https://doi.org/10.4070/kcj.2007.37.2.64
  13. Sutton-Tyrrell K, Zhao X, Santoro N, Lasley B, Sowers M, Johnston J, Mackey R, Matthews K. Reproductive hormones and obesity: 9 years of observation from the study of women's health across the nation. Am J Epidemiol 171:1203-1213, 2010 https://doi.org/10.1093/aje/kwq049
  14. Carney PI. Obesity and reproductive hormone levels in the transition to menopause. Menopause 17:678-679, 2010 https://doi.org/10.1097/gme.0b013e3181e3a10a
  15. Bagur R, Bertrand OF, Rodes-Cabau J, Rinfret S, Larose E, Tizon-Marcos H, Gleeton O, Nguyen CM, Roy L, Costerousse O, De Larochellière R. Comparison of outcomes in patients > or = 70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome. Am J Cardiol 104:624-629, 2009 https://doi.org/10.1016/j.amjcard.2009.04.050
  16. Fang J, Alderman MH. Gender differences of revascularization in patients with acute myocardial infarction. Am J Cardiol 97: 1722-1726, 2006 https://doi.org/10.1016/j.amjcard.2006.01.032
  17. Aggarwal A, Dai D, Rumsfeld JS, Klein LW, Roe MT. Incidence and predictors of stroke associated with percutaneous coronary intervention. Am J Cardiol 104:349-353, 2009 https://doi.org/10.1016/j.amjcard.2009.03.046
  18. Yang B, Choi MJ, Jeong MH, Kim JH, Park WS, Park OY, Kim IS, Rhew JY, Kim W, Ahn YK, Cho JG, Park JC, Ahn BH, Kim SH, Kang JC. The effect of gender on short-and long-term clinical outcomes of percutaneous coronary intervention in Korean octogenarians. Korean Circ J 32:864-871, 2002
  19. Lee YS, Jeong MH, Kim KH, Kang DG, Yun KH, Lee SH, Lim SY, Hong SN, Park HW, Hong YJ, Kim JH, Kim W, Ahn YK, Cho JG, Park JC, Kang JC. The relationship between hemoglobin A1c and major adverse cardiac events in nondiabetic acute myocardial infarction patients underwent primary percutaneous coronary intervention. Korean Circ J 35:369-374, 2005 https://doi.org/10.4070/kcj.2005.35.5.369
  20. Kuch B, Wende R, Barac M, von Scheidt W, Kling B, Greschik C, Meisinger C. Prognosis and outcomes of elderly (75-84years) patients with acute myocardial infarction 1-2years after the event: AMI-elderly study of the MONICA/KORA myocardial infarction registry. Int J Cardiol 2010 [Epub ahead of print]
  21. Radovanvic D, Erne P. AMIS Plus: Swiss registry of acute coronary syndrome. Heart 96:917-921, 2010 https://doi.org/10.1136/hrt.2009.192302
  22. Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360:2503-2515, 2009 https://doi.org/10.1056/NEJMoa0805796
  23. Andron M, Perry RA, Egred M Alahmar AE, Grayson AD, Shaw M, Roberts E, Palmer ND, Stables RH. The impact of diabetes mellitus on two-year mortality following contemporary percutaneous coronary intervention: implications for revascularization practice. J Interv Cardiol 22:420-426, 2009 https://doi.org/10.1111/j.1540-8183.2009.00471.x
  24. Yoo WS, Kim HJ, Kim D, Lee MY, Chung HK. Early detection of asymptomatic coronary artery disease in patients with type 2 diabetes mellitus. Korean J Intern Med 24:183-189, 2009 https://doi.org/10.3904/kjim.2009.24.3.183
  25. Sedlis SP, Jurkovitz CT, Hartigan PM, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, O'Rourke RA, Boden WE, Weintraub WS. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. Am J Cardiol 104:1647-1653, 2009 https://doi.org/10.1016/j.amjcard.2009.07.043
  26. Yoon YE, Rivera JJ, Kwon DA, Chae IH, Jeong MH, Rha SW, Blumenthal RS, Nasir K, Chang HJ. National cholesterol education panel III guidelines performance role in preventing myocardial infarction in a large cohort without a history of coronary artery disease: Korea acute myocardial infarction registry study. Prev Cardiol 12:109-113, 2009 https://doi.org/10.1111/j.1751-7141.2009.00030.x
  27. Savic L, Mrdovic I, Perunicic J, Asanin M, Lasica R, Marinkovic J, Vasiljevic Z, Ostojic M. Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary intervention. J Invasive Cardiol 22:307-311, 2010
  28. Saguner AM, Dur S, Perrig M, Schiemann U, Stuck AE, Burgi U, Erne P, Schoenenberger AW. Risk factors promoting hypertensive crises: evidence from a longitudinal study. Am J Hypertens 23:775-780, 2010 https://doi.org/10.1038/ajh.2010.71
  29. Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, Schron EB, Lindholm LH, Fagard R, Staessen JA, Gueyffier F. Treatment of hypertension in patients 80 years and older: the lower the better?: a meta-analysis of randomized controlled trials. J Hypertens 28:1366-1372, 2010 https://doi.org/10.1097/HJH.0b013e328339f9c5
  30. Shenoy C, Orshaw P, Devarakonda S, Harjai KJ. Occurrence, predictors, and outcomes of post-percutaneous coronary intervention thrombocytopenia In an unselected population. J Interv Cardiol 22:156-162, 2009 https://doi.org/10.1111/j.1540-8183.2009.00424.x